Asia-Pacific In Vitro Fertilization Market is Expected to Reach $4,021.3 million, by 2021


Posted July 22, 2015 by apacmarket

In Vitro Fertilization (IVF) Asia-Pacific Market Research Report, 2014 -2021

 
A new report published by apacmarket.com, titled, “In Vitro Fertilization (IVF) Asia-Pacific Market Research Report, 2014 -2021", forecasts the in vitro fertilization market in Asia-Pacific to reach $4,021.3 million by 2021. China would continue to lead the market throughout forecast period with revenue of $1,273.9 million in 2021. However, India is projected to register the highest growth during 2015-2021, both in terms of cycles and revenue.
IVF procedures have emerged as a preferable choice for the fertility treatment in Asia-Pacific. Factors, such as the delayed pregnancies due professional commitments, rise in lifestyle driven infertility, growing trends towards financial stability, and emergence of new fertility tourism destinations is largely contributing to the growth of the Asia-Pacific IVF market. However, factors such as high costs, ethical and religious considerations, inadequate IVF reimbursements are likely to restrain the market growth

Get more information on IVF at: http://www.apacmarket.com/top-market/in-vitro-fertilization-market

The average age of parenthood in the region has sharply inclined over the last decade. Over two thirds of babies in the region are born to a father over the age of 30 years and about 45% of women conceive at age of 30 years and above, for the first time. The stats are even worse in countries such as Japan, Korea, Singapore and Australia. The growing aging population has been the major concern for government in most of the countries in the region. Countries such as Indonesia, Vietnam, Cambodia and Philippines have fertility rates in excess of 2; however, they are keen to boost their fertility rates to counter the large aging population. Indonesia in particular has a fertility rate of 2.1 but has 210 million people within geriatric age. Korea, which has fertility rate of 1.4, has announced financial support for infertility treatment while Singapore with fertility rate of 1.3 has increased the subsidies for treatment to 75% of the treatment cost. All these have been instrumental in driving the growth of IVF market in Asia Pacific. It is expected that, in 2021, over 1.5 million IVF cycles would be performed in Asia Pacific.

The fertility treatment providers such as fertility clinics, hospitals and surgical centers are invariably competing to gain the edge in the ever growing market. Fertility clinics and hospitals had collectively contributed about 80% of the Asia-Pacific IVF market revenue in 2014, owing to their sophisticated and highly advanced treatments. Moreover, specialized fertility clinics have grown in numbers recently with growing patient preference. As a result, the fertility clinic segment has consolidate its revenue share and would continue to do so over the forecast period.

India and China would emerge as key fertility tourism destinations during the forecast period, largely due to factors such as favorable government regulations, availability of skilled workforce and economical pricing of hospital services compared to other global fertility-treatment destinations. The considerable growth in these countries would be supplemented by the increased rate of infertilities, practices of donor egg IVF cycles, and embryo banking.

Key findings of the study:
• India, China and Japan had collectively accounted for about 80% of the total cycles performed in 2014
• In India, the fertility clinics and hospitals segment had collectively accounted for about 82% of the revenue generated in 2014
• China generated largest revenue in 2014
• The IVF market in India is expected to register a promising CAGR of 13.2% during 2015–2021 in terms of number of cycles performed

The key IVF centers profiled in this report include, Cloudnine, Bloom Fertility Center, Nova IVI Fertility, Vitrolife AB, EMD Serono, Inc., Iwaki Women’s clinic, Genea Biomedx, Monash IVF, Repromed, Maria Fertility Hospital, Bangkok Fertility Center, CRM-MIA Philippines, IVFAS and others.

About Us
With cutting edge innovative solution, ApacMarket.com is a world leader in providing market research strategies in Asia Pacific region. We make a comprehensive coverage of Asia Pacific market so that you understand your customers and markets in-depth. Offering unbiased data and minute details of this region, ApacMarket.com ensures you and your organization best research strategies to implement. Keeping your organization's need in mind, our team of experts provides you with the finest of market and customer information along with socio-economic status of the region.

We operate on multi-knowledge chain to provide you with deep analysis, useful information, actionable insights that will help you and you're organization in strategically planning your business moves. Our highly qualified and well experienced analysts will give you a deep understanding of local, national and global events that will prove immensely beneficial to your business needs.

ApacMarket.com formed with the intention to deliver best research services; provides you with unmatchable actionable business insights and solutions. ApacMarket.com has demonstrated high potential to locate opportunities for business expansion. We have a powerful knack to present the ground realities of your consumers and markets like no one else.

Contact Us
Syed Ali
Level 32, 101 Miller Street,
North Sydney, NSW 2060
International: +61-280 454 214
Landline: +91 (20) 60604041 (India)
Email: [email protected]
Web - http://www.apacmarket.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Apac Market
Website Apac Market
Phone +61280454214
Business Address Level 32, 101 Miller Street, North Sydney, NSW 2060 Australia
Country Australia
Categories Medical
Tags asiapacific in vitro fertilization market , in vitro fertilization market
Last Updated July 22, 2015